Bottom Line: Sermorelin vs BPC-157 Sermorelin and BPC-157 serve different purposes
Reproductive and developmental safety are not established
Critical Safety Gaps for Mental Health Applications Unknown effects on cognitive function, memory, personality, mood stability beyond intended therapeutic effect Long-term impacts on brain chemistry (chronic administration effects unexplored beyond 6 weeks in animals) Potential for psychological dependence or tolerance (not studied systematically) Impacts on developing brains in adolescents and young adults (completely unknown with no pediatric studies) Drug Interactions Pose Serious Concerns BPC-157s simultaneous effects on serotonin, dopamine, GABA, glutamate, and nitric oxide systems create multiple theoretical interaction points with psychiatric medications, yet interactions are not well studied. Specific concerns include: With SSRIs and SNRIs: Risk of serotonin syndrome is genuine
When you work with a medical team like the one at Formation, your progress is actively monitored
A boost in prevention or treatment of diabetic neuropathy
It usually ranges from 1 mg to 2.5 mg per shot